» Articles » PMID: 31229673

Self-assembled Amphiphilic Copolymers As Dual Delivery System for Immunotherapy

Overview
Specialty Pharmacology
Date 2019 Jun 24
PMID 31229673
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Subunit vaccines using recombinant antigens appear as the privileged vaccination technology for safety reasons but still require the development of carriers/adjuvants ensuring optimal immunogenicity and efficacy. Micelles from self-assembled amphiphilic copolymers have recently emerged as highly relevant and promising candidates owing to their ease of preparation, low size (entering in lymphatic capillaries for reaching lymph nodes), size/surface tunability and chemical versatility enabling introduction of stimuli (e.g. pH) responsive features and biofunctionalization with dedicated molecules. In particular, research efforts have increasingly focused on dendritic cells (DCs) targeting and activation by co-delivering (with antigen) ligands of pattern recognition receptors (PRRs, e.g. toll-like receptors). Such strategy has appeared as one of the most effective for eliciting CD 8+ T-cell response, which is crucial in the eradication of tumors and numerous infectious diseases. In this short review, we highlight the recent advances in such micelle-based carriers in subunit vaccination and how their precise engineering can be a strong asset for guiding and controlling immune responses.

Citing Articles

A novel nanomicelle composed from PEGylated TB di-peptide could be successfully used as a BCG booster.

Firouzi Z, Jaafari M, Sankian M, Zare S, Tafaghodi M Iran J Basic Med Sci. 2022; 25(2):223-231.

PMID: 35655599 PMC: 9124544. DOI: 10.22038/IJBMS.2022.61373.13583.


A Polylactide-Based Micellar Adjuvant Improves the Intensity and Quality of Immune Response.

Lamrayah M, Phelip C, Coiffier C, Lacroix C, Willemin T, Trimaille T Pharmaceutics. 2022; 14(1).

PMID: 35057003 PMC: 8778782. DOI: 10.3390/pharmaceutics14010107.


Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform.

Sa-Nguanmoo N, Namdee K, Khongkow M, Ruktanonchai U, Zhao Y, Liang X Nano Res. 2021; 15(3):2196-2225.

PMID: 34659650 PMC: 8501370. DOI: 10.1007/s12274-021-3832-y.


Recent Advances and Future Perspectives in Polymer-Based Nanovaccines.

Pippa N, Gazouli M, Pispas S Vaccines (Basel). 2021; 9(6).

PMID: 34073648 PMC: 8226647. DOI: 10.3390/vaccines9060558.


Wedelolactone-Loaded Micelles Ameliorate Doxorubicin-Induced Oxidative Injury in Podocytes by Improving Permeability and Bioavailability.

Feng L, Li Z, Wang L, Li X, Chen Y, Yang B Front Bioeng Biotechnol. 2019; 7:333.

PMID: 31824933 PMC: 6883003. DOI: 10.3389/fbioe.2019.00333.